Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Schrimpf

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Acta Neuropathologica Communications|January 11, 2022
Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survivalAzadeh Ebrahimi, Andrey Korshunov, Guido Reifenberger, et al.
Acta Neuropathologica|August 11, 2018
Correction to: DNA methylation-based reclassification of olfactory neuroblastomaDavid Capper, Nils W Engel, Damian Stichel, et al.
Neuro-Oncology|April 18, 2025
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genesPhilipp Sievers, Sonali Arora, Thomas Hielscher, et al.
Acta Neuropathologica|May 7, 2018
DNA methylation-based reclassification of olfactory neuroblastomaDavid Capper, Nils W Engel, Damian Stichel, et al.
Acta Neuropathologica|April 20, 2021
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1Abigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Acta Neuropathologica|February 14, 2019
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCAYanghao Hou, Jorge Pinheiro, Felix Sahm, et al.
Neuro-Oncology|June 3, 2026
Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all AgesAbigail K Suwala, Dennis Friedel, Felix E Hinz, et al.
Acta Neuropathologica|November 26, 2025
Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomasFelix E Hinz, Dennis Friedel, Franziska M Ippen, et al.
Neuro-Oncology|July 22, 2025
Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted and TERTp-wildtype: a grade 1 oligodendroglioma of young patients?Filippo Nozzoli, Ramin Rahmanzade, Simone Schmid, et al.
Acta Neuropathologica Communications|October 30, 2019
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entitiesAnnekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica Communications|January 11, 2022
Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survivalAzadeh Ebrahimi, Andrey Korshunov, Guido Reifenberger, et al.
Acta Neuropathologica|August 11, 2018
Correction to: DNA methylation-based reclassification of olfactory neuroblastomaDavid Capper, Nils W Engel, Damian Stichel, et al.
Neuro-Oncology|April 18, 2025
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genesPhilipp Sievers, Sonali Arora, Thomas Hielscher, et al.
Acta Neuropathologica|May 7, 2018
DNA methylation-based reclassification of olfactory neuroblastomaDavid Capper, Nils W Engel, Damian Stichel, et al.
Acta Neuropathologica|April 20, 2021
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1Abigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Acta Neuropathologica|February 14, 2019
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCAYanghao Hou, Jorge Pinheiro, Felix Sahm, et al.
Neuro-Oncology|June 3, 2026
Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all AgesAbigail K Suwala, Dennis Friedel, Felix E Hinz, et al.
Acta Neuropathologica|November 26, 2025
Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomasFelix E Hinz, Dennis Friedel, Franziska M Ippen, et al.
Neuro-Oncology|July 22, 2025
Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted and TERTp-wildtype: a grade 1 oligodendroglioma of young patients?Filippo Nozzoli, Ramin Rahmanzade, Simone Schmid, et al.
Acta Neuropathologica Communications|October 30, 2019
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entitiesAnnekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Pageof 13